SCIENTIFIC HUB

Follow the evidence.

106.961 articles found

Open access

Neuroprotective efficacy of berberine and caffeine against rotenone-induced neuroinflammatory and oxidative disturbances associated with Parkinson's disease via inhibiting α-synuclein aggregation and boosting dopamine release.

Waheeb TS, Abdulkader MA, Ghareeb DA, Moustafa ME.

Inflammopharmacology · 2025-03-09

DOI: 10.1007/s10787-025-01661-wPMID: 40057928

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Microstructural patterns in substantia nigra subregions are associated with depression and olfactory impairments in Parkinson's disease.

Mozafar M, Manshadi ZD, Molaei Z, Babaei H, Mansouri M, Shahbazi S, Shakeri S, Mirhosseini H, Gulisashvili D, Mayeli M, Parkinson’s Progression Markers Initiative (PPMI).

Clin Neurol Neurosurg · 2025-03-08

DOI: 10.1016/j.clineuro.2025.108817PMID: 40080943

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Update on Treatments for Parkinson's Disease Motor Fluctuations - An International Parkinson and Movement Disorder Society Evidence-Based Medicine Review.

de Bie RMA, Katzenschlager R, Swinnen BEKS, Peball M, Lim SY, Mestre TA, Perez Lloret S, Coelho M, Aquino C, Tan AH, Bruno V, Dijk JM, Heim B, Lin CH, Kauppila LA, Litvan I, Spijker R, Seppi K, Costa J, Sampaio C, Fox SH, Silverdale MA.

Mov Disord · 2025-03-08

DOI: 10.1002/mds.30162PMID: 40055961

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.